RBC LIFE SCIENCES, INC. Financials

PERIOD ENDING30-Sep-0930-Jun-0931-Mar-0931-Dec-08Total Revenue6,487  6,759  6,016  7,250  Cost of Revenue3,272  3,238  2,877  3,664  Gross Profit3,215  3,521  3,139  3,586  Operating ExpensesResearch Development -   -   -   -  Selling General and Administrative3,274  2,921  3,212  3,149  Non Recurring -   -   -   -  Others95  93  88  85  Total Operating Expenses -   -   -   -  Operating Income or Loss(154)508  (161)352  Income from Continuing OperationsTotal Other Income/Expenses Net -   -   -   -  Earnings Before Interest And Taxes(154)508  (161)352  Interest Expense41  41  42  43  Income Before Tax(195)466  (203)310  Income Tax Expense(43)189  (32)171  Minority Interest -   -   -   -  Net Income From Continuing Ops(152)277  (171)139  Non-recurring EventsDiscontinued Operations -   -   -   -  Extraordinary Items -   -   -   -  Effect Of Accounting Changes -   -   -   -  Othe...
Click here to read the whole Article (external link)

RBC LIFE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results ofOperations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere in this report and the audited consolidated financial statements and notes thereto included in the 2008 Form 10-K. FORWARD-LOOKING STATEMENTS The statements, other than statements of historical or present facts, included in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical or present facts, that address activities, events, outcomes and other matters that we plan, expect, intend, assume, believe, budget, predict, forecast, project, estimate or anticipate (and other similar expressions) will, should or may occur in the future are forward-looking statements. Forward-looking statements can be identified by the use of the words "may," "will," "expect," "intend," "estimate," "anticipate," "objective," "projection," forecast," "goal," "believe," and similar expressions. These forward-looking statements are based on management's current belief, based on currently available information, as to the outcome and time of future events. We believe that the expectations and assumptions reflected in these forward-looking statements are reasonable. However, we cannot assure you that such expectations will occur. Our actual future performance could differ materially from such statements. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this Form 10-Q and those previously disclosed in Item 1A to Part I of the 2008 Form 10-K. Many of these facto...
Click here to read the whole Article (external link)

RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area

IRVING, Texas, Nov. 9 /PRNewswire-FirstCall/ -- RBC Life Sciences, Inc. (OTC Bulletin Board: RBCL - News), a provider of proprietary nutritional supplements and wound care/pain management products, has been named one of the Top 100 workplaces in the Dallas-Fort Worth area. The Dallas Morning News, the Top 100 Places to Work 2009 competition surveyed more than 33,400 employees at hundreds of small, medium and large firms throughout the DFW metropolitan area. The employees ranked their companies on merits such as corporate leadership, compensation, training, workplace flexibility and diversity.RBC Life Sciences, which was ranked as the area's 57th best workplace, was one of only 22 small companies to make the Top 100 Places to Work 2009."Employees are the life blood of any organization," said RBC Life Sciences President and CEO, John W. Price. "It's humbling that our employees, even in the midst of trying economic times that require workplace sacrifices, showed they are satisfied."About RBC Life SciencesRBC Life Sciences develops, manufactures and markets quality nutritional supplements and personal care products to a growing population of consumers under the auspices of its networking marketing arm, ...
Click here to read the whole Article (external link)

RBC LIFE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere in this report and the audited consolidated financial statements and notes thereto included in the 2008 Form 10-K. FORWARD-LOOKING STATEMENTS The statements, other than statements of historical or present facts, included in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical or present facts, that address activities, events, outcomes and other matters that we plan, expect, intend, assume, believe, budget, predict, forecast, project, estimate or anticipate (and other similar expressions) will, should or may occur in the future are forward-looking statements. Forward-looking statements can be identified by the use of the words "may," "will," "expect," "intend," "estimate," "anticipate," "objective," "projection," forecast," "goal," "believe," and similar expressions. These forward-looking statements are based on management's current belief, based on currently available information, as to the outcome and time of future events. We believe that the expectations and assumptions reflected in these forward-looking statements are reasonable. However, we cannot assure you that such expectations will occur. Our actual future performance could differ materially from such statements. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this Form 10-Q and those previously disclosed in Item 1A to Part I of the 2008 Form 10-K. Many of these ...
Click here to read the whole Article (external link)

RBC LIFE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E

Show all filings for RBC LIFE SCIENCES, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for RBC LIFE SCIENCES, INC. 6-Aug-2009Results of Operations and Financial Condition, Financial Statements and E Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pro...
Click here to read the whole Article (external link)

RBC LIFE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E

Show all filings for RBC LIFE SCIENCES, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for RBC LIFE SCIENCES, INC. 8-May-2009Results of Operations and Financial Condition, Financial Statements and E Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pro...
Click here to read the whole Article (external link)

RBC LIFE SCIENCES, INC. Files SEC form 10-K, Annual Report

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and analysis of financial condition and results of operations should be read in conjunction with the audited consolidated financial statements and notes thereto appearing elsewhere in this report. Overview We operate in two industry segments, Nutritional Products and Medical Products. • Through the Nutritional Products segment, we distribute products in three broad categories: (i) wellness products, (ii) fitness products and (iii) skin care products. Products include herbal formulas, vitamins, minerals, antioxidants and personal care products. In certain markets, principally in the U.S. and Canada, we distribute Nutritional Products directly through a network of independent Associates. In certain international markets, we distribute Nutritional Products through exclusive license arrangements with third parties, who for the most part, distribute our products through an independent Associate network in the licensed territory. • Through the Medical Products segment, we distribute wound care products. These products are distributed primarily in the U.S. to hospitals, nursing homes, clinics and pharmacies through traditional medical/surgical supply dealers and pharmaceutical distributors. Medical Products are used to prevent and treat wounds, and manage pain associated with wounds, in the acute care, long-term care, oncology and podiatry markets. Table of Contents Net sales. Consolidated net sales in dollars and as a percentage of consolidated net sales are as follows: Associate network. We sell Nutritional Products to Associates who purchase products for personal consumption or for resale to retail customers; Associates also sponsor new Associates who also engage in these activities. Consequently, sales in this distribution channel are dependent upon the number and productivity of our Assoc...
Click here to read the whole Article (external link)